{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:05:35Z","timestamp":1767650735665},"reference-count":35,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Aesthet Surg"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/jcas.jcas_68_21","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T09:18:15Z","timestamp":1658308695000},"page":"168","source":"Crossref","is-referenced-by-count":4,"title":["Incobotulinum toxin A with a one-year long-lasting effect for trapezius contouring and superior efficacy for the treatment of trapezius myalgia"],"prefix":"10.25259","volume":"15","author":[{"given":"Napamon","family":"Supornpun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paisal","family":"Rummaneethorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thamthiwat","family":"Nararatwanchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawee","family":"Saiwichai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirinthip","family":"Chaichalotornkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0974-2077.351505-1","doi-asserted-by":"crossref","unstructured":"De Meulemeester K, Calders P, De Pauw R, Grymonpon I, Govaerts A, Cagnie B Morphological and physiological differences in the upper trapezius muscle in patients with work-related trapezius myalgia compared to healthy controls: A systematic review. Musculoskelet Sci Pract 2017;29:43-51.","DOI":"10.1016\/j.msksp.2017.02.007"},{"key":"key-10.4103\/0974-2077.351505-2","doi-asserted-by":"crossref","unstructured":"Larsson B, S\u00f8gaard K, Rosendal L Work-related neck\/shoulder pain: A review on the magnitude, risk factors, biochemical characteristics, clinical picture, and preventive interventions. Best Pract Res: Clin Rheumatol 2007;21:447-63.","DOI":"10.1016\/j.berh.2007.02.015"},{"key":"key-10.4103\/0974-2077.351505-3","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan C, Meaney J, Boyle G, Gormley J, Stokes M The validity of rehabilitative ultrasound imaging for measurement of trapezius muscle thickness. Man Ther 2009;14:572-8.","DOI":"10.1016\/j.math.2008.12.005"},{"key":"key-10.4103\/0974-2077.351505-4","unstructured":"Kwanchuay P, Petchnumsin T, Yiemsiri P, Pasuk N, Srikanok W, Hathaiareerug C Efficacy and safety of single botulinum toxin type A (Botox\u00ae) injection for relief of upper trapezius myofascial trigger point: A randomised, double blind, placebo control study. J Med Assoc Thai 2015;98:1231-6."},{"key":"key-10.4103\/0974-2077.351505-5","doi-asserted-by":"crossref","unstructured":"Dashtipour K, Chen JJ, Walker HW, Lee MY Systematic literature review of abobotulinum toxin A in clinical trials for adult upper limb spasticity. Am J Phys Med Rehabil 2015;94:229-38.","DOI":"10.1097\/PHM.0000000000000208"},{"key":"key-10.4103\/0974-2077.351505-6","doi-asserted-by":"crossref","unstructured":"Park MY, Ahn KY, Jung DS Botulinum toxin type A treatment for contouring of the lower face. Dermatol Surg 2003;29:477-83; discussion 483.","DOI":"10.1046\/j.1524-4725.2003.29116.x"},{"key":"key-10.4103\/0974-2077.351505-7","doi-asserted-by":"crossref","unstructured":"Saad J, Gourdeau A A direct comparison of onabotulinum toxin A (Botox\u00ae) and incobotulinum toxin A (Xeomin\u00ae) in the treatment of benign essential blepharospasm: A split-face technique. J Neuro-Ophthalmol 2014;34:233-6.","DOI":"10.1097\/WNO.0000000000000110"},{"key":"key-10.4103\/0974-2077.351505-8","doi-asserted-by":"crossref","unstructured":"Pirazzini M, Rossetto O, Eleopra R, Montecucco C Botulinum neurotoxins: Biology, pharmacology, and toxicology. Pharmacol Rev 2017;69:200-35.","DOI":"10.1124\/pr.116.012658"},{"key":"key-10.4103\/0974-2077.351505-9","doi-asserted-by":"crossref","unstructured":"Samizadeh S, De Boulle K Botulinum neurotoxin formulations: Overcoming the confusion. Clin Cosmet Investig Dermatol 2018;11:273-87.","DOI":"10.2147\/CCID.S156851"},{"key":"key-10.4103\/0974-2077.351505-10","doi-asserted-by":"crossref","unstructured":"Scaglione F Conversion ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in clinical practice. Toxin 2016;8:65.","DOI":"10.3390\/toxins8030065"},{"key":"key-10.4103\/0974-2077.351505-11","unstructured":"Mastromauro L, Trerotolli P, Romanelli E, Marvulli RG, Ranieri G Incobotulinum toxin A (Xeomin\u00ae) versus onabotulinum toxin A (Botox\u00ae): Evaluation of clinical onset of action with rating scales and electroneurography. Int J Neurorehabilit Eng 2015;2:1000182."},{"key":"key-10.4103\/0974-2077.351505-12","doi-asserted-by":"crossref","unstructured":"Ferrari A, Manca M, Tugnoli V, Alberto L Pharmacological differences and clinical implications of various botulinum toxin preparations: A critical appraisal. Funct Neurol 2018;33:7-18.","DOI":"10.11138\/FNeur\/2018.33.1.007"},{"key":"key-10.4103\/0974-2077.351505-13","doi-asserted-by":"crossref","unstructured":"Frevert J Xeomin is free from complexing proteins. Toxicon 2009;54:697-701.","DOI":"10.1016\/j.toxicon.2009.03.010"},{"key":"key-10.4103\/0974-2077.351505-14","doi-asserted-by":"crossref","unstructured":"Frevert J Content of botulinum neurotoxin in Botox\u00ae\/Vistabel\u00ae, Dysport\u00ae\/Azzalure\u00ae, and Xeomin\u00ae\/Bocouture\u00ae. Drugs R D 2010;10:67-73.","DOI":"10.2165\/11584780-000000000-00000"},{"key":"key-10.4103\/0974-2077.351505-15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00702-012-0854-3","article-title":"Comparative evaluation of the potency and antigenicity of two distinct BoNT\/A-derived formulations","author":"Brown","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"key":"key-10.4103\/0974-2077.351505-16","doi-asserted-by":"crossref","unstructured":"Hunt T, Clarke K Potency evaluation of a formulated drug product containing 150-kd botulinum neurotoxin type A. Clin Neuropharmacol 2009;32:28-31.","DOI":"10.1097\/WNF.0b013e3181692735"},{"key":"key-10.4103\/0974-2077.351505-17","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/iai.64.5.1589-1594.1996","article-title":"Molecular composition of clostridium botulinum type A progenitor toxins","author":"Inoue","year":"1996","journal-title":"Infect Immun"},{"key":"key-10.4103\/0974-2077.351505-18","doi-asserted-by":"crossref","unstructured":"Dressler D, Benecke R Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 2007;29:1761-8.","DOI":"10.1080\/09638280701568296"},{"key":"key-10.4103\/0974-2077.351505-19","doi-asserted-by":"crossref","unstructured":"Chundury RV, Couch SM, Holds JB Comparison of preferences between onabotulinum toxin A (Botox) and incobotulinum toxin A (Xeomin) in the treatment of benign essential blepharospasm. Ophthalmic Plast Reconstr Surg 2013;29:205-7.","DOI":"10.1097\/IOP.0b013e31828de0d6"},{"key":"key-10.4103\/0974-2077.351505-20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","article-title":"Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm","author":"Roggenk\u00e4mper","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"key":"key-10.4103\/0974-2077.351505-21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/CCID.S41537","article-title":"Onset and duration of effect of incobotulinum toxin A, onabotulinum toxin A, and abobotulinum toxin A in the treatment of glabellar frown lines: A randomized, double-blind study","author":"Rappl","year":"2013","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"key-10.4103\/0974-2077.351505-22","doi-asserted-by":"crossref","unstructured":"Frevert J, Dressler D Complexing proteins in botulinum toxin type A drugs: A help or a hindrance? Biologics 2010;4:325-32.","DOI":"10.2147\/BTT.S14902"},{"key":"key-10.4103\/0974-2077.351505-23","doi-asserted-by":"crossref","unstructured":"Stengel G, Bee EK Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines. Clin Interv Aging 2011;6:281-4.","DOI":"10.2147\/CIA.S18997"},{"key":"key-10.4103\/0974-2077.351505-24","doi-asserted-by":"crossref","unstructured":"Benedetto AV Botulinum toxins in clinical aesthetic practice. 2nd ed. London: Informa Healthcare; 2011. p. 954.","DOI":"10.3109\/9781841847559"},{"key":"key-10.4103\/0974-2077.351505-25","doi-asserted-by":"crossref","unstructured":"Park G, Choi YC, Bae JH, Kim ST Does botulinum toxin injection into masseter muscles affect subcutaneous thickness? Aesthet Surg J 2018;38:192-8.","DOI":"10.1093\/asj\/sjx102"},{"key":"key-10.4103\/0974-2077.351505-26","doi-asserted-by":"crossref","unstructured":"Salavati M, Akhbari B, Ebrahimi Takamjani I, Ezzati K, Haghighatkhah H Reliability of the upper trapezius muscle and fascia thickness and strain ratio measures by ultrasonography and sonoelastography in participants with myofascial pain syndrome. J Chiropr Med 2017;16:316-23.","DOI":"10.1016\/j.jcm.2017.06.003"},{"key":"key-10.4103\/0974-2077.351505-27","unstructured":"Westad C Motor control of the upper trapezius. Trondheim, Norway: Department of Biology, Norwegian University of Science and Technology; 2005. p. 8."},{"key":"key-10.4103\/0974-2077.351505-28","doi-asserted-by":"crossref","unstructured":"Nagrale AV, Glynn P, Joshi A, Ramteke G The efficacy of an integrated neuromuscular inhibition technique on upper trapezius trigger points in subjects with non-specific neck pain: A randomized controlled trial. J Man Manip Ther 2010;18: 37-43.","DOI":"10.1179\/106698110X12595770849605"},{"key":"key-10.4103\/0974-2077.351505-29","doi-asserted-by":"crossref","unstructured":"Kierner AC, Zelenka I, Heller S, Burian M Surgical anatomy of the spinal accessory nerve and the trapezius branches of the cervical plexus. Arch Surg 2000;135:1428-31.","DOI":"10.1001\/archsurg.135.12.1428"},{"key":"key-10.4103\/0974-2077.351505-30","doi-asserted-by":"crossref","unstructured":"Kelley MJ, Kane TE, Leggin BG Spinal accessory nerve palsy: Associated signs and symptoms. J Orthop Sports Phys Ther 2008;38:78-86.","DOI":"10.2519\/jospt.2008.2454"},{"key":"key-10.4103\/0974-2077.351505-31","doi-asserted-by":"crossref","unstructured":"Ramirez-Castaneda J, Jankovic J, Comella C, Dashtipour K, Fernandez HH, Mari Z Diffusion, spread, and migration of botulinum toxin. Mov Disord 2013;28:1775-83.","DOI":"10.1002\/mds.25582"},{"key":"key-10.4103\/0974-2077.351505-32","doi-asserted-by":"crossref","unstructured":"Chen F, Kuziemko GM, Amersdorfer P, Wong C, Marks JD, Stevens RC Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms. Infect Immun 1997;65:1626-30.","DOI":"10.1128\/iai.65.5.1626-1630.1997"},{"key":"key-10.4103\/0974-2077.351505-33","doi-asserted-by":"crossref","unstructured":"Wanitphakdeedecha R, Ungaksornpairote C, Kaewkes A, Sathaworawong A, Vanadurongwan B, Lektrakul N A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring. J Cosmet Dermatol2018;17: 984-90.","DOI":"10.1111\/jocd.12787"},{"key":"key-10.4103\/0974-2077.351505-34","doi-asserted-by":"crossref","unstructured":"Shome D, Vadera S, Shiva Ram M, Kapoor R Efficacy of incobotulinum toxin-A for the treatment of masseter muscle hypertrophy in Asian Indian patients: A 2-year follow-up study. J Cosmet Dermatol 2020;19:1892-9.","DOI":"10.1111\/jocd.13552"},{"key":"key-10.4103\/0974-2077.351505-35","doi-asserted-by":"crossref","unstructured":"Alter K, Karp B Ultrasound guidance for botulinum neurotoxin chemodenervation procedure. Toxins (Basel) 2018;10:18.","DOI":"10.3390\/toxins10010018"}],"container-title":["Journal of Cutaneous and Aesthetic Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T07:16:04Z","timestamp":1725088564000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcasonline.com\/incobotulinum-toxin-a-with-a-one-year-long-lasting-effect-for-trapezius-contouring-and-superior-efficacy-for-the-treatment-of-trapezius-myalgia\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"alternative-id":["351505"],"URL":"https:\/\/doi.org\/10.4103\/jcas.jcas_68_21","relation":{},"ISSN":["0974-2077"],"issn-type":[{"type":"print","value":"0974-2077"}],"subject":[],"published":{"date-parts":[[2022]]}}}